Clínica Mayo de UMCB SRL
Clínica Mayo de UMCB SRL cuenta con acreditación ITAES en la ciudad de San Miguel de Tucumán cuenta con el Centro de Investigación a cargo del Director del Dpto de Investigación Clínica: Dr Conrado Llapur, 3 Coordinadoras, más de 10 investigadores clínicos con experiencia en diferentes especialidades (Cardiología, Endocrinología, Neumonología, Infectología, Reumatología, Pediatría, Ginecología y Obstetricía, Psiquiatría) 1 bioquímicoSelect an option
I am a doctor
I am a sponsor
Specializations
Cardiología
Endocrinología
Neumología
Infectología
Reumatología
Pedriatría
Ginecología
Our team
Medical staff
Luis Adolfo Moyano
Maria Virginia Mansilla
Conrado Juan Llapur
Maria Eugenia Valdez
Open studies
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-2 - BiogenSee more
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST) - AMETHYST - BiogenSee more
Rare diseases
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity - Oasiz - Horizon Therapeutics Ireland DACSee more
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State - AmgenSee more
Asthma
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more
Heart failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
Pubertal Development Disorder
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial) - LIBELULA - Debiopharm International SASee more
Urticaria
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria - EMBARQ-CSU1 - Celldex TherapeuticsSee more
